Home PACS News PACS Corporate News Controversies in Lung Cancer Screening
Controversies in Lung Cancer Screening PDF Print E-mail
Written by PACSMule Administrator   
Sunday, 31 January 2016 17:00
There remains an extensive debate over lung cancer screening, with lobbying for and against screening for very compelling reasons. The National Lung Screening Trial, International Early Lung Cancer Program, and other major screening studies favor screening with low-dose CT scans and have shown a reduction in lung cancer–specific mortality. The increasing incidence of lung cancer and the dismal survival rate for advanced disease despite improved multimodality therapy have sparked an interest in the implementation of national lung cancer screening.

Read more